ABBV logo

AbbVie (ABBV) Shareholders Equity

Annual Shareholders Equity

$10.36 B
-$6.89 B-39.96%

31 December 2023

ABBV Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$6.03 B
-$746.00 M-11.01%

30 September 2024

ABBV Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABBV Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-40.0%-50.1%
3 y3 years-20.8%-55.5%
5 y5 years+222.7%+173.3%

ABBV Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-40.0%at low-65.0%at low
5 y5 years-40.0%+222.7%-65.0%+173.3%
alltimeall time-40.0%+222.7%-65.0%+170.4%

AbbVie Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$6.03 B(-11.0%)
June 2024
-
$6.78 B(-15.3%)
Mar 2024
-
$8.01 B(-22.7%)
Dec 2023
$10.36 B(-40.0%)
$10.36 B(-14.3%)
Sept 2023
-
$12.09 B(-6.0%)
June 2023
-
$12.87 B(-3.1%)
Mar 2023
-
$13.27 B(-23.1%)
Dec 2022
$17.25 B(+12.0%)
$17.25 B(+7.9%)
Sept 2022
-
$15.99 B(+9.2%)
June 2022
-
$14.65 B(-10.0%)
Mar 2022
-
$16.28 B(+5.7%)
Dec 2021
$15.41 B(+17.8%)
$15.41 B(+13.7%)
Sept 2021
-
$13.55 B(+7.8%)
June 2021
-
$12.57 B(-8.3%)
Mar 2021
-
$13.71 B(+4.8%)
Dec 2020
$13.08 B(-260.0%)
$13.08 B(-14.4%)
Sept 2020
-
$15.27 B(+3.8%)
June 2020
-
$14.71 B(-298.4%)
Mar 2020
-
-$7.42 B(-9.3%)
Dec 2019
-$8.17 B(-3.2%)
-$8.17 B(-0.7%)
Sept 2019
-
-$8.23 B(-4.0%)
June 2019
-
-$8.57 B(+9.5%)
Mar 2019
-
-$7.83 B(-7.3%)
Dec 2018
-$8.45 B
-$8.45 B(+189.1%)
Sept 2018
-
-$2.92 B(-13.5%)
June 2018
-
-$3.38 B(-195.0%)
DateAnnualQuarterly
Mar 2018
-
$3.55 B(-30.3%)
Dec 2017
$5.10 B(+9.9%)
$5.10 B(-23.8%)
Sept 2017
-
$6.69 B(+11.3%)
June 2017
-
$6.01 B(+20.2%)
Mar 2017
-
$5.00 B(+7.8%)
Dec 2016
$4.64 B(+17.5%)
$4.64 B(-28.3%)
Sept 2016
-
$6.47 B(+14.7%)
June 2016
-
$5.64 B(+21.5%)
Mar 2016
-
$4.64 B(+17.7%)
Dec 2015
$3.94 B(+126.5%)
$3.94 B(-18.9%)
Sept 2015
-
$4.86 B(-11.6%)
June 2015
-
$5.50 B(+299.7%)
Mar 2015
-
$1.38 B(-21.0%)
Dec 2014
$1.74 B(-61.2%)
$1.74 B(-62.5%)
Sept 2014
-
$4.64 B(-11.0%)
June 2014
-
$5.22 B(+11.1%)
Mar 2014
-
$4.70 B(+4.6%)
Dec 2013
$4.49 B(+33.6%)
$4.49 B(+25.6%)
Sept 2013
-
$3.58 B(+0.5%)
June 2013
-
$3.56 B(+20.3%)
Mar 2013
-
$2.96 B(-12.1%)
Dec 2012
$3.36 B(-71.8%)
$3.36 B(-78.5%)
Sept 2012
-
$15.67 B(+36.2%)
June 2012
-
$11.51 B(-4.5%)
Mar 2012
-
$12.05 B(+1.0%)
Dec 2011
$11.93 B(-24.0%)
$11.93 B
Dec 2010
$15.70 B
-

FAQ

  • What is AbbVie annual stockholders equity?
  • What is the all time high annual shareholders equity for AbbVie?
  • What is AbbVie annual shareholders equity year-on-year change?
  • What is AbbVie quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for AbbVie?
  • What is AbbVie quarterly shareholders equity year-on-year change?

What is AbbVie annual stockholders equity?

The current annual shareholders equity of ABBV is $10.36 B

What is the all time high annual shareholders equity for AbbVie?

AbbVie all-time high annual stockholders equity is $17.25 B

What is AbbVie annual shareholders equity year-on-year change?

Over the past year, ABBV annual stockholders equity has changed by -$6.89 B (-39.96%)

What is AbbVie quarterly stockholders equity?

The current quarterly shareholders equity of ABBV is $6.03 B

What is the all time high quarterly shareholders equity for AbbVie?

AbbVie all-time high quarterly stockholders equity is $17.25 B

What is AbbVie quarterly shareholders equity year-on-year change?

Over the past year, ABBV quarterly stockholders equity has changed by -$6.06 B (-50.12%)